Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Implementing Regulation (EU) 2026/1806 of 24 July 2026 amending Regulation (EU) No 37/2010 as regards the classification of the substance recombinant equine chorionic gonadotropin with respect to its maximum residue limit in foodstuffs of animal origin
Data as of 2026-08-20 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the following entry is inserted in alphabetical order: Pharmaco-logically active substance Marker residue Animal species MRL Target Tissues Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification ‘Recombinant equine chorionic gonadotropin (reCG, recombinant analogues of pregnant mare serum gonadotrophin) – chemical-unlike biological substance NOT APPLICABLE All food-producing species No MRL required NOT APPLICABLE NO ENTRY NO ENTRY’
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.